Neurogene Inc. Foreign Currency Transaction Loss, before Tax
Neurogene Inc. (NGNE) reported Foreign Currency Transaction Loss, before Tax of $26.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2016-05-10
- Neurogene Inc. foreign currency transaction loss, before tax for the quarter ending 2016-03-31 was $26.00K, a 93.12% decline year-over-year.
- Neurogene Inc. foreign currency transaction loss, before tax for the quarter ending 2015-03-31 was $378.00K.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month |
|---|---|
| 2016-03-31 | $26.00K 10-Q · filed 2016-05-10 |
| 2015-03-31 | $378.00K 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |